
Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401

Operating Margin
Zhejiang Garden Bio-chemical High-tech Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
CN |
![]() |
Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
|
8B CNY |
30%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
704.6B USD |
40%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
373.1B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
45%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
210.7B CHF |
33%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
185.7B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
164B GBP |
24%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
191B USD |
34%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
133.1B USD |
27%
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
Glance View
Zhejiang Garden Bio-chemical High-tech Co Ltd, nestled in the economic heart of China, boasts a robust presence in the global vitamin industry. Established with a keen focus on biosynthesis, the company has carved a niche for itself by specializing in the production of Vitamin D3. As a key player in the vitamin sector, Garden Bio-chemical uses advanced biotechnological methods to convert raw materials such as lanolin, derived from sheep's wool, into highly purified Vitamin D3. This complex process involves carefully monitored steps of extraction and fermentation, ensuring the production of high-quality vitamins that meet stringent international standards. The company’s financial health is intricately tied to its ability to meet the rising demand for vitamins across diverse markets, particularly in health-conscious segments. With the growing global emphasis on nutrition and wellness, Garden Bio-chemical capitalizes on this trend by enhancing its production capabilities and expanding its market reach. The company's revenue model relies heavily on large-scale contracts with pharmaceutical companies, dietary supplement manufacturers, and other sectors that require consistent and reliable supplies of Vitamin D3. By maintaining strong relationships with its clients and continuing to innovate in its production processes, Zhejiang Garden Bio-chemical High-tech Co Ltd ensures sustainability and profitability in an increasingly competitive market.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Zhejiang Garden Bio-chemical High-tech Co Ltd's most recent financial statements, the company has Operating Margin of 29.9%.